human adipose sv cells Search Results


99
Thermo Fisher subcutaneous adipose tissue
Subcutaneous Adipose Tissue, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/subcutaneous adipose tissue/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
subcutaneous adipose tissue - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

93
Alomone Labs adi anti aqp3 antibody
Adi Anti Aqp3 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adi anti aqp3 antibody/product/Alomone Labs
Average 93 stars, based on 1 article reviews
adi anti aqp3 antibody - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
Alpha Diagnostics primary antibodies against mouse adipor1 and adipor2, which cross-react with human adipors
Expression of monocyte <t>AdipoRs,</t> AdipoR1 and AdipoR2, is altered in IR (GINF < 4.0) subjects compared with IS (GINF > 7.5) subjects. IS is determined by euglycemic clamp and expressed as the GINF. Data are mean ± SD, n = 5/group; *P < 0.01 vs. IS.
Primary Antibodies Against Mouse Adipor1 And Adipor2, Which Cross React With Human Adipors, supplied by Alpha Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against mouse adipor1 and adipor2, which cross-react with human adipors/product/Alpha Diagnostics
Average 90 stars, based on 1 article reviews
primary antibodies against mouse adipor1 and adipor2, which cross-react with human adipors - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

95
Miltenyi Biotec 15713s recombinant april mouse multimeric adipo gen life sciences
Expression of monocyte <t>AdipoRs,</t> AdipoR1 and AdipoR2, is altered in IR (GINF < 4.0) subjects compared with IS (GINF > 7.5) subjects. IS is determined by euglycemic clamp and expressed as the GINF. Data are mean ± SD, n = 5/group; *P < 0.01 vs. IS.
15713s Recombinant April Mouse Multimeric Adipo Gen Life Sciences, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/15713s recombinant april mouse multimeric adipo gen life sciences/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
15713s recombinant april mouse multimeric adipo gen life sciences - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

90
BioWhittaker Molecular Applications human mesenchymal stem cells (hmsc)
Expression of monocyte <t>AdipoRs,</t> AdipoR1 and AdipoR2, is altered in IR (GINF < 4.0) subjects compared with IS (GINF > 7.5) subjects. IS is determined by euglycemic clamp and expressed as the GINF. Data are mean ± SD, n = 5/group; *P < 0.01 vs. IS.
Human Mesenchymal Stem Cells (Hmsc), supplied by BioWhittaker Molecular Applications, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human mesenchymal stem cells (hmsc)/product/BioWhittaker Molecular Applications
Average 90 stars, based on 1 article reviews
human mesenchymal stem cells (hmsc) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
ScienCell endothelial cells human adipose microvascular ec (hamvec)
A: Averaged curves and quantitation of trans- <t>endothelial</t> electrical resistance (TER) of untreated or PIC treated HAMVECs for 24 hours. TER was monitored in confluent cell monolayers for 24 hours using an electric cell substrate impedance sensor instrument (ECSIS). Data was quantitated using area under curve (AUC) and the results from three different experiments performed in triplicate were presented as average±SD. B: Averaged curves showing the “wound closure” kinetics of untreated and PIC treated cells for 24 hours prior to application of the wound. Wound closure was expressed as speed of closure (μm/hr). Data represent average from three independent experiments performed in duplicate. C: Representative micrographs and quantitation of <t>HAMVEC</t> proliferation using BrDU incorporation assay. Untreated or PIC treated cells for either 1 or 6 days were plated on fibronectin-coated chamber slides and incubated with BrDU for 24 hours. Cell nuclei are stained blue with DAPI. Nuclei of the proliferating cells are stained green using a FITC-labeled BrDU antibody. Overlapping images of the same field show both proliferating cells (light blue nuclei) and non-proliferating cells (dark blue, DAPI only). Magnification is 200x (Scale Bar=50-μm). Quantitation was done by calculation of % of BrDU stained cells to total cells. Data is expressed as % proliferation of PIC treated cells compared to control cells for each of the 1hr and 6 hr time points ± SD. For each experimental condition, three independent experiments with cells from three independent donors were performed in duplicate and 3 different areas for each replicate were imaged and counted. Cells between passages 4–7 were used in all experiments. Statistical analysis was performed using paired Student’s t-test between PIC and control samples.
Endothelial Cells Human Adipose Microvascular Ec (Hamvec), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endothelial cells human adipose microvascular ec (hamvec)/product/ScienCell
Average 90 stars, based on 1 article reviews
endothelial cells human adipose microvascular ec (hamvec) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology human tissue extracts
A: Averaged curves and quantitation of trans- <t>endothelial</t> electrical resistance (TER) of untreated or PIC treated HAMVECs for 24 hours. TER was monitored in confluent cell monolayers for 24 hours using an electric cell substrate impedance sensor instrument (ECSIS). Data was quantitated using area under curve (AUC) and the results from three different experiments performed in triplicate were presented as average±SD. B: Averaged curves showing the “wound closure” kinetics of untreated and PIC treated cells for 24 hours prior to application of the wound. Wound closure was expressed as speed of closure (μm/hr). Data represent average from three independent experiments performed in duplicate. C: Representative micrographs and quantitation of <t>HAMVEC</t> proliferation using BrDU incorporation assay. Untreated or PIC treated cells for either 1 or 6 days were plated on fibronectin-coated chamber slides and incubated with BrDU for 24 hours. Cell nuclei are stained blue with DAPI. Nuclei of the proliferating cells are stained green using a FITC-labeled BrDU antibody. Overlapping images of the same field show both proliferating cells (light blue nuclei) and non-proliferating cells (dark blue, DAPI only). Magnification is 200x (Scale Bar=50-μm). Quantitation was done by calculation of % of BrDU stained cells to total cells. Data is expressed as % proliferation of PIC treated cells compared to control cells for each of the 1hr and 6 hr time points ± SD. For each experimental condition, three independent experiments with cells from three independent donors were performed in duplicate and 3 different areas for each replicate were imaged and counted. Cells between passages 4–7 were used in all experiments. Statistical analysis was performed using paired Student’s t-test between PIC and control samples.
Human Tissue Extracts, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human tissue extracts/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
human tissue extracts - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology adiponectin goat anti mouse igg hrp
Patient characteristics.
Adiponectin Goat Anti Mouse Igg Hrp, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adiponectin goat anti mouse igg hrp/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
adiponectin goat anti mouse igg hrp - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

94
BioVendor Instruments human adiponectin
Patient characteristics.
Human Adiponectin, supplied by BioVendor Instruments, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human adiponectin/product/BioVendor Instruments
Average 94 stars, based on 1 article reviews
human adiponectin - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Enzo Biochem human recombinant adiponectin
Patient characteristics.
Human Recombinant Adiponectin, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human recombinant adiponectin/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
human recombinant adiponectin - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

93
R&D Systems recombinant mouse adiponectin 5095 ac
Patient characteristics.
Recombinant Mouse Adiponectin 5095 Ac, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse adiponectin 5095 ac/product/R&D Systems
Average 93 stars, based on 1 article reviews
recombinant mouse adiponectin 5095 ac - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
Nosan Corporation recombinant human adiponectin
Patient characteristics.
Recombinant Human Adiponectin, supplied by Nosan Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human adiponectin/product/Nosan Corporation
Average 90 stars, based on 1 article reviews
recombinant human adiponectin - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Expression of monocyte AdipoRs, AdipoR1 and AdipoR2, is altered in IR (GINF < 4.0) subjects compared with IS (GINF > 7.5) subjects. IS is determined by euglycemic clamp and expressed as the GINF. Data are mean ± SD, n = 5/group; *P < 0.01 vs. IS.

Journal: The FASEB Journal

Article Title: Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response

doi: 10.1096/fj.14-253831

Figure Lengend Snippet: Expression of monocyte AdipoRs, AdipoR1 and AdipoR2, is altered in IR (GINF < 4.0) subjects compared with IS (GINF > 7.5) subjects. IS is determined by euglycemic clamp and expressed as the GINF. Data are mean ± SD, n = 5/group; *P < 0.01 vs. IS.

Article Snippet: The membrane was blocked (5% fat-free milk in Tris-buffered saline/0.01% Tween 20) and exposed to the primary antibodies against mouse AdipoR1 and AdipoR2, which cross-react with human AdipoRs (Alpha Diagnostics, San Antonio, TX, USA), AMPK, phospho-AMPK, p38, phospho-p38, or β -actin (Abcam, San Francisco, CA, USA) overnight at 4°C.

Techniques: Expressing

A: Averaged curves and quantitation of trans- endothelial electrical resistance (TER) of untreated or PIC treated HAMVECs for 24 hours. TER was monitored in confluent cell monolayers for 24 hours using an electric cell substrate impedance sensor instrument (ECSIS). Data was quantitated using area under curve (AUC) and the results from three different experiments performed in triplicate were presented as average±SD. B: Averaged curves showing the “wound closure” kinetics of untreated and PIC treated cells for 24 hours prior to application of the wound. Wound closure was expressed as speed of closure (μm/hr). Data represent average from three independent experiments performed in duplicate. C: Representative micrographs and quantitation of HAMVEC proliferation using BrDU incorporation assay. Untreated or PIC treated cells for either 1 or 6 days were plated on fibronectin-coated chamber slides and incubated with BrDU for 24 hours. Cell nuclei are stained blue with DAPI. Nuclei of the proliferating cells are stained green using a FITC-labeled BrDU antibody. Overlapping images of the same field show both proliferating cells (light blue nuclei) and non-proliferating cells (dark blue, DAPI only). Magnification is 200x (Scale Bar=50-μm). Quantitation was done by calculation of % of BrDU stained cells to total cells. Data is expressed as % proliferation of PIC treated cells compared to control cells for each of the 1hr and 6 hr time points ± SD. For each experimental condition, three independent experiments with cells from three independent donors were performed in duplicate and 3 different areas for each replicate were imaged and counted. Cells between passages 4–7 were used in all experiments. Statistical analysis was performed using paired Student’s t-test between PIC and control samples.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Article Title: Endothelial to Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction

doi: 10.1161/ATVBAHA.119.312826

Figure Lengend Snippet: A: Averaged curves and quantitation of trans- endothelial electrical resistance (TER) of untreated or PIC treated HAMVECs for 24 hours. TER was monitored in confluent cell monolayers for 24 hours using an electric cell substrate impedance sensor instrument (ECSIS). Data was quantitated using area under curve (AUC) and the results from three different experiments performed in triplicate were presented as average±SD. B: Averaged curves showing the “wound closure” kinetics of untreated and PIC treated cells for 24 hours prior to application of the wound. Wound closure was expressed as speed of closure (μm/hr). Data represent average from three independent experiments performed in duplicate. C: Representative micrographs and quantitation of HAMVEC proliferation using BrDU incorporation assay. Untreated or PIC treated cells for either 1 or 6 days were plated on fibronectin-coated chamber slides and incubated with BrDU for 24 hours. Cell nuclei are stained blue with DAPI. Nuclei of the proliferating cells are stained green using a FITC-labeled BrDU antibody. Overlapping images of the same field show both proliferating cells (light blue nuclei) and non-proliferating cells (dark blue, DAPI only). Magnification is 200x (Scale Bar=50-μm). Quantitation was done by calculation of % of BrDU stained cells to total cells. Data is expressed as % proliferation of PIC treated cells compared to control cells for each of the 1hr and 6 hr time points ± SD. For each experimental condition, three independent experiments with cells from three independent donors were performed in duplicate and 3 different areas for each replicate were imaged and counted. Cells between passages 4–7 were used in all experiments. Statistical analysis was performed using paired Student’s t-test between PIC and control samples.

Article Snippet: Endothelial cells Human adipose microvascular EC (HAMVEC) were purchased from ScienCell Research Laboratories (cat#: 7200, Lot #: 5439).

Techniques: Quantitation Assay, BrdU Incorporation Assay, Incubation, Staining, Labeling, Control

HAMVEC with or without PIC treatment for 1day (A) or 6 days (B) were labeled with calcein, seeded in growth factor reduced Matrigel coated plates and incubated for 6 hours before imaging. Representative micrographs (top panels) show reduced formation of branches and reduced tubule length in PIC treated cells, which were totally blunted after 6 days of treatment; Magnification 40x (Scale Bar=200-μm). Angiogenesis was quantified as average numbers of branches and average tubule lengths in three independent experiments performed in triplicate. Three different pictures for each replicate were analyzed using the Image J Angiogenesis software and data was represented as average ±SD. ND = not detectable. Data represents average of three independent experiments performed in duplicate using EC from 3 individual donors on passages 4–7. Data is expressed as the mean+/−SD. Comparisons were performed using paired Student’s t-test.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Article Title: Endothelial to Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction

doi: 10.1161/ATVBAHA.119.312826

Figure Lengend Snippet: HAMVEC with or without PIC treatment for 1day (A) or 6 days (B) were labeled with calcein, seeded in growth factor reduced Matrigel coated plates and incubated for 6 hours before imaging. Representative micrographs (top panels) show reduced formation of branches and reduced tubule length in PIC treated cells, which were totally blunted after 6 days of treatment; Magnification 40x (Scale Bar=200-μm). Angiogenesis was quantified as average numbers of branches and average tubule lengths in three independent experiments performed in triplicate. Three different pictures for each replicate were analyzed using the Image J Angiogenesis software and data was represented as average ±SD. ND = not detectable. Data represents average of three independent experiments performed in duplicate using EC from 3 individual donors on passages 4–7. Data is expressed as the mean+/−SD. Comparisons were performed using paired Student’s t-test.

Article Snippet: Endothelial cells Human adipose microvascular EC (HAMVEC) were purchased from ScienCell Research Laboratories (cat#: 7200, Lot #: 5439).

Techniques: Labeling, Incubation, Imaging, Software

A: Oxygen consumption rate (OCR) was utilized to assess endothelial metabolism in HAMVECs stimulated with PICs for 6 days using a Mitochondrial Stress Test. Cells were seeded into Seahorse XFe24 plates at 50,000 cells/well and allowed to attach and grow for 24 hours until they reached 70–80%confluence. Respiration data was normalized to total cellular protein. B: Proton efflux rate due to glycolysis (GlycoPER) was measured using the glycolysis stress kit in cells seeded in similar conditions as above. Data is normalized to total protein. C: Fatty acid oxidation was measured using palmitate-BSA as a substrate according to a protocol detailed in Methods section. For this assays cells were allowed to reach 100% confluence. Etomoxir (4uM) was used as a positive control for inhibition of beta-oxidation D: Phenogram showing extracellular acidification and oxygen consumption; E: Gene expression of Cpt1, Cpt2 and Acly was measured in control and PIC-treated HAMVEC for 6 days by real-time PCR; F: Western blotting and semi-quantitation of CPT1a expression in HAMVEC treated with PIC for 6 days and untreated controls.G: miR-155–5p measured by real-time PCR in PIC-treated cells for 6 days compared to controls. H: Diagram showing proposed scenario involving down regulation of CPT1, and ACLY via miR-155–5p leading to an overall reduction in HAMVEC metabolism in response to PIC treatment. Data represents average of three independent experiments performed in duplicate using EC from 3 individual donors on passages 4–8. Data is expressed as the mean+/−SD.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Article Title: Endothelial to Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction

doi: 10.1161/ATVBAHA.119.312826

Figure Lengend Snippet: A: Oxygen consumption rate (OCR) was utilized to assess endothelial metabolism in HAMVECs stimulated with PICs for 6 days using a Mitochondrial Stress Test. Cells were seeded into Seahorse XFe24 plates at 50,000 cells/well and allowed to attach and grow for 24 hours until they reached 70–80%confluence. Respiration data was normalized to total cellular protein. B: Proton efflux rate due to glycolysis (GlycoPER) was measured using the glycolysis stress kit in cells seeded in similar conditions as above. Data is normalized to total protein. C: Fatty acid oxidation was measured using palmitate-BSA as a substrate according to a protocol detailed in Methods section. For this assays cells were allowed to reach 100% confluence. Etomoxir (4uM) was used as a positive control for inhibition of beta-oxidation D: Phenogram showing extracellular acidification and oxygen consumption; E: Gene expression of Cpt1, Cpt2 and Acly was measured in control and PIC-treated HAMVEC for 6 days by real-time PCR; F: Western blotting and semi-quantitation of CPT1a expression in HAMVEC treated with PIC for 6 days and untreated controls.G: miR-155–5p measured by real-time PCR in PIC-treated cells for 6 days compared to controls. H: Diagram showing proposed scenario involving down regulation of CPT1, and ACLY via miR-155–5p leading to an overall reduction in HAMVEC metabolism in response to PIC treatment. Data represents average of three independent experiments performed in duplicate using EC from 3 individual donors on passages 4–8. Data is expressed as the mean+/−SD.

Article Snippet: Endothelial cells Human adipose microvascular EC (HAMVEC) were purchased from ScienCell Research Laboratories (cat#: 7200, Lot #: 5439).

Techniques: Positive Control, Inhibition, Gene Expression, Control, Real-time Polymerase Chain Reaction, Western Blot, Quantitation Assay, Expressing

A: Nanoparticle size distribution of extracellular vesicles (EV) isolated from untreated control cells (EV-C) and from PIC-treated cells (EV-PIC) shows an average peak size of 140–150-nm for both EV preparations. B: Representative micrographs of negative staining electron microscopy of EV-PIC and EV-C confirms the presence of EVs in the size range calculated by nanoparticle tracking analysis in both preparations; C: Nanosight analysis shows a 3-fold higher number of EV-PIC/cell compared to EV-C. This difference was consistent across 12 different EV preparations from control and PIC treated cells. D: Western blot showing expression of various markers in control and PIC treated cells and in EV-C and EV-PIC extracellular vesicles. Exosomal markers syntenin-1 and CD9 are enriched in both EV-PIC and EV-C compared to parent cells and CD63 and HSP70 were present in both EV preparations; calnexin (microsomal marker) and LAMP1 (lysosomal marker) were not detectable in either one of the EV preparations. E: diagram showing experimental protocol for EV production, isolation and incubation with recipient cells. F: EV-PIC and EV-C were labeled with the fluorescent lipophilic dye Vybrant DiO and incubated with EC overnight; representative micrographs show uptake by HAMVEC at 37°C and show dramatic reduction of uptake at 22°C, suggesting an energy dependent uptake mechanism; magnification 100x (Scale Bar=100-μm); higher magnification inset shows the peri-nuclear distribution of the labeled EVs. G: Quantitative analysis of EV uptake using flow cytometry of the HAMVEC cells after 24 h incubation with labeled EVs. Representative flow cytometry plots show the background control that was subtracted from the uptake data (left panel); negative control (center left) and EV-PIC and EV-C representative uptake plots. Concentration dependent uptake was determined in pilot experiments. Results shown here are from incubation of 105 cells with 1010 EV-C or EV-PIC for 24 hours. Data is expressed as mean of % cell uptake ± SD and shows no difference between uptake of EV-C and EV-PIC. Results are from 3 independent experiments, performed in duplicate, using cells from 3 separate donors, on passages 4–5.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Article Title: Endothelial to Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction

doi: 10.1161/ATVBAHA.119.312826

Figure Lengend Snippet: A: Nanoparticle size distribution of extracellular vesicles (EV) isolated from untreated control cells (EV-C) and from PIC-treated cells (EV-PIC) shows an average peak size of 140–150-nm for both EV preparations. B: Representative micrographs of negative staining electron microscopy of EV-PIC and EV-C confirms the presence of EVs in the size range calculated by nanoparticle tracking analysis in both preparations; C: Nanosight analysis shows a 3-fold higher number of EV-PIC/cell compared to EV-C. This difference was consistent across 12 different EV preparations from control and PIC treated cells. D: Western blot showing expression of various markers in control and PIC treated cells and in EV-C and EV-PIC extracellular vesicles. Exosomal markers syntenin-1 and CD9 are enriched in both EV-PIC and EV-C compared to parent cells and CD63 and HSP70 were present in both EV preparations; calnexin (microsomal marker) and LAMP1 (lysosomal marker) were not detectable in either one of the EV preparations. E: diagram showing experimental protocol for EV production, isolation and incubation with recipient cells. F: EV-PIC and EV-C were labeled with the fluorescent lipophilic dye Vybrant DiO and incubated with EC overnight; representative micrographs show uptake by HAMVEC at 37°C and show dramatic reduction of uptake at 22°C, suggesting an energy dependent uptake mechanism; magnification 100x (Scale Bar=100-μm); higher magnification inset shows the peri-nuclear distribution of the labeled EVs. G: Quantitative analysis of EV uptake using flow cytometry of the HAMVEC cells after 24 h incubation with labeled EVs. Representative flow cytometry plots show the background control that was subtracted from the uptake data (left panel); negative control (center left) and EV-PIC and EV-C representative uptake plots. Concentration dependent uptake was determined in pilot experiments. Results shown here are from incubation of 105 cells with 1010 EV-C or EV-PIC for 24 hours. Data is expressed as mean of % cell uptake ± SD and shows no difference between uptake of EV-C and EV-PIC. Results are from 3 independent experiments, performed in duplicate, using cells from 3 separate donors, on passages 4–5.

Article Snippet: Endothelial cells Human adipose microvascular EC (HAMVEC) were purchased from ScienCell Research Laboratories (cat#: 7200, Lot #: 5439).

Techniques: Isolation, Control, Negative Staining, Electron Microscopy, Western Blot, Expressing, Marker, Incubation, Labeling, Flow Cytometry, Negative Control, Concentration Assay

HAMVEC were incubated for 24 hours with either EV-C, EV-PIC or were left untreated. Following treatment, cells were labeled with calcein, seeded in growth factor reduced matrigel coated plates and incubated for 6 hours before imaging. Representative micrographs (top panels) showing reduced formation of branches and reduced tubule length in HAMVEC treated with EV-PIC compared to untreated cells; Magnification 40x (Scale Bar=200-μm). Treatment with EV-PIC severely impaired tube network parameters compared to untreated control cells and EV-C treated cells. Angiogenesis was quantified in three independent experiments performed in triplicate. Three different pictures for each replicate were analyzed using the Image J Angiogenesis Analyzer software and data was represented as average ±SD. B: Oxygen consumption rate (OCR) was utilized to assess endothelial metabolism in cells treated with EV-C or EV-PIC using a Mitochondrial Stress Test. Cells were seeded into Seahorse XFe24 plates and allowed to attach and grow for 24 hours until they reached 70–80% confluence . Respiration data was normalized to total cellular protein. B: Proton efflux rate due to glycolysis (GlycoPER) was measured using the glycolysis stress kit in cells seeded in similar conditions as above. Data is normalized to total protein. C: Fatty acid oxidation was measured using palmitate-BSA as a substrate according to a protocol detailed in Methods section. For this assays cells were allowed to reach 100% confluence. Etomoxir (Eto) (4uM) was used as a positive control for inhibition of beta-oxidation Data represents average of three independent experiments performed in duplicate on cells from 3 individual donors on passages 4–6 and are expressed as the mean+/−SD.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Article Title: Endothelial to Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction

doi: 10.1161/ATVBAHA.119.312826

Figure Lengend Snippet: HAMVEC were incubated for 24 hours with either EV-C, EV-PIC or were left untreated. Following treatment, cells were labeled with calcein, seeded in growth factor reduced matrigel coated plates and incubated for 6 hours before imaging. Representative micrographs (top panels) showing reduced formation of branches and reduced tubule length in HAMVEC treated with EV-PIC compared to untreated cells; Magnification 40x (Scale Bar=200-μm). Treatment with EV-PIC severely impaired tube network parameters compared to untreated control cells and EV-C treated cells. Angiogenesis was quantified in three independent experiments performed in triplicate. Three different pictures for each replicate were analyzed using the Image J Angiogenesis Analyzer software and data was represented as average ±SD. B: Oxygen consumption rate (OCR) was utilized to assess endothelial metabolism in cells treated with EV-C or EV-PIC using a Mitochondrial Stress Test. Cells were seeded into Seahorse XFe24 plates and allowed to attach and grow for 24 hours until they reached 70–80% confluence . Respiration data was normalized to total cellular protein. B: Proton efflux rate due to glycolysis (GlycoPER) was measured using the glycolysis stress kit in cells seeded in similar conditions as above. Data is normalized to total protein. C: Fatty acid oxidation was measured using palmitate-BSA as a substrate according to a protocol detailed in Methods section. For this assays cells were allowed to reach 100% confluence. Etomoxir (Eto) (4uM) was used as a positive control for inhibition of beta-oxidation Data represents average of three independent experiments performed in duplicate on cells from 3 individual donors on passages 4–6 and are expressed as the mean+/−SD.

Article Snippet: Endothelial cells Human adipose microvascular EC (HAMVEC) were purchased from ScienCell Research Laboratories (cat#: 7200, Lot #: 5439).

Techniques: Incubation, Labeling, Imaging, Control, Software, Positive Control, Inhibition

Patient characteristics.

Journal: Journal of Clinical Medicine

Article Title: Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors

doi: 10.3390/jcm11154333

Figure Lengend Snippet: Patient characteristics.

Article Snippet: Secondary antibody reactions were performed at room temperature for 1 h. The antibodies used in the assay were DPP-4 and adiponectin goat anti-mouse IgG-HRP (sc-2005, Santa Cruz Biotech-nology, Inc., Dallas, TX, USA).

Techniques: Biomarker Discovery, Activity Assay

Comparison of dipeptidyl peptidase 4 (DPP-4), adiponectin, and tumor necrosis factor α (TNFα) expression in subcutaneous and epicardial adipose tissue. ( a ) Expression of DPP-4 in subcutaneous and epicardial adipose tissue. ( b ) Expression of adiponectin in subcutaneous and epicardial adipose tissue. ( c ) Expression of TNFα in subcutaneous and epicardial adipose tissue.

Journal: Journal of Clinical Medicine

Article Title: Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors

doi: 10.3390/jcm11154333

Figure Lengend Snippet: Comparison of dipeptidyl peptidase 4 (DPP-4), adiponectin, and tumor necrosis factor α (TNFα) expression in subcutaneous and epicardial adipose tissue. ( a ) Expression of DPP-4 in subcutaneous and epicardial adipose tissue. ( b ) Expression of adiponectin in subcutaneous and epicardial adipose tissue. ( c ) Expression of TNFα in subcutaneous and epicardial adipose tissue.

Article Snippet: Secondary antibody reactions were performed at room temperature for 1 h. The antibodies used in the assay were DPP-4 and adiponectin goat anti-mouse IgG-HRP (sc-2005, Santa Cruz Biotech-nology, Inc., Dallas, TX, USA).

Techniques: Comparison, Expressing

Correlation between DPP-4 and other parameters in serum, subcutaneous adipose tissue, and epicardial adipose tissue.

Journal: Journal of Clinical Medicine

Article Title: Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors

doi: 10.3390/jcm11154333

Figure Lengend Snippet: Correlation between DPP-4 and other parameters in serum, subcutaneous adipose tissue, and epicardial adipose tissue.

Article Snippet: Secondary antibody reactions were performed at room temperature for 1 h. The antibodies used in the assay were DPP-4 and adiponectin goat anti-mouse IgG-HRP (sc-2005, Santa Cruz Biotech-nology, Inc., Dallas, TX, USA).

Techniques: Activity Assay

Correlations between ( a ) serum and SAT adiponectin, ( b ) serum and EAT adiponectin, and ( c ) SAT and EAT adiponectin.

Journal: Journal of Clinical Medicine

Article Title: Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors

doi: 10.3390/jcm11154333

Figure Lengend Snippet: Correlations between ( a ) serum and SAT adiponectin, ( b ) serum and EAT adiponectin, and ( c ) SAT and EAT adiponectin.

Article Snippet: Secondary antibody reactions were performed at room temperature for 1 h. The antibodies used in the assay were DPP-4 and adiponectin goat anti-mouse IgG-HRP (sc-2005, Santa Cruz Biotech-nology, Inc., Dallas, TX, USA).

Techniques:

Correlation between  adiponectin  and other parameters in serum, subcutaneous adipose tissue, and epicardial adipose tissue.

Journal: Journal of Clinical Medicine

Article Title: Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors

doi: 10.3390/jcm11154333

Figure Lengend Snippet: Correlation between adiponectin and other parameters in serum, subcutaneous adipose tissue, and epicardial adipose tissue.

Article Snippet: Secondary antibody reactions were performed at room temperature for 1 h. The antibodies used in the assay were DPP-4 and adiponectin goat anti-mouse IgG-HRP (sc-2005, Santa Cruz Biotech-nology, Inc., Dallas, TX, USA).

Techniques: Activity Assay

Characteristics of patient groups taking DPP-4 inhibitors and those not taking them.

Journal: Journal of Clinical Medicine

Article Title: Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors

doi: 10.3390/jcm11154333

Figure Lengend Snippet: Characteristics of patient groups taking DPP-4 inhibitors and those not taking them.

Article Snippet: Secondary antibody reactions were performed at room temperature for 1 h. The antibodies used in the assay were DPP-4 and adiponectin goat anti-mouse IgG-HRP (sc-2005, Santa Cruz Biotech-nology, Inc., Dallas, TX, USA).

Techniques: Biomarker Discovery, Activity Assay